Microsoft word - msds_6epidoxycycline hydrochloride_cat871.doc

BRITISH PHARMACOPOEIA CHEMICAL REFERENCE SUBSTANCE
MATERIAL SAFETY DATA SHEET

The substance to which this Safety Data Sheet relates is supplied exclusively as a British Pharmacopoeia Chemical Reference Substance
(BPCRS) for chemical test and assay purposes. It is not intended to be used for any other purpose and is not for human consumption.
The BPCRS is supplied in accordance with the Terms of Trade and Supply as set out in the catalogue. The information set out in this sheet is
applicable solely to the substance when used as a BPCRS and is not intended to apply to any other use or preparation of the substance (e.g. at
different concentrations, in drug dosage form or in bulk quantities).
The information which follows has been assembled from sources considered reliable, in particular from material provided in the ordinary way by
the manufacturer or supplier. It has not been independently verified by the British Pharmacopoeia. The accuracy of the information cannot
therefore be guaranteed, nor does it constitute any expression of opinion by the British Pharmacopoeia concerning the substance. This
information is not to be regarded as a representation or statement concerning the quality or safety of the substance except that of use as a
BPCRS by professional persons having technical skill and at their own discretion and risk.
All persons using BPCRS materials must determine the risks associated with the substance depending on the actual conditions of use and
should take appropriate measures.
Information given in sections 2, 3, 4, 5, 6, 9, 10, 11, 12 and 13 relates to the bulk substance and is not necessarily relevant to the BPCRS
regarding the small quantities contained in vials. Information in sections 1, 7, 8 and 14 applies only to the BPCRS.
1. IDENTIFICATION OF THE SUBSTANCE AND OF THE COMPANY

6-EPIDOXYCYCLINE HYDROCHLORIDE BPCRS
Caution! This product is a synthesis by-product and/or a degradation product. Its properties have not been fully investigated.
Information given in this MSDS refers to the parent compound; doxycycline hyclate.

British Pharmacopoeia Commission
Secretariat

Telephone: +44 (0)20 3080 6561 (office hours)
Email: [email protected]
Emergency telephone: +44 (0)20 3080 6561 (office hours)
Reference standard for laboratory use
2. HAZARDS IDENTIFICATION
Harmful by inhalation, in contact with skin and if swallowed. Irritating to eyes, respiratory system and skin. Possible risk of harm to the unborn
child. May cause harm to breastfed babies. May cause an allergic reaction, especially in case of pre-existing sensitivity to similar substances,
such as, tetracyclines and cephalosporins. Increases skin photosensitivity. May be harmful to the environment.
Symbol: Xn
R phrases: R20/21/22, R36/37/38, R63, R64
3. COMPOSITION/INFORMATION ON INGREDIENTS

(C22H25ClN2O8),½C2H6O,½H2O (doxycycline hyclate)

4. FIRST AID MEASURES

Inhalation: Remove to fresh air. If breathing becomes difficult, call a physician.
Skin contact: Flush with copious amounts of water and soap for at least 15 minutes. Remove contaminated clothing and shoes.
Eye contact: Assure adequate flushing by separating the eyelids with fingers. Flush with copious amounts of water for at least 15 minutes.
Ingestion: Wash out mouth with water and administer fresh water provided that the person is conscious.
In any case seek medical advice and call the nearest poison centre. Show the label and this safety data sheet.

5. FIRE FIGHTING MEASURES

Extinguishing media: Water spray. Carbon dioxide, dry chemical powder or appropriate foam. Avoid overspills into drains, surface and
groundwater and soil.
Dust may form explosive mixture in air. Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes.
Emits toxic fumes under fire conditions.
Dangerous combustion products: COx, NOx, HCl and other noxious gases or vapours in case of incomplete combustion.
6. ACCIDENTAL RELEASE MEASURES

Wear self-contained breathing apparatus, rubber boots and heavy rubber gloves. Switch off sources of ignition and intense heat. Collect
residues manually, wipe with sodium hypochlorite until all residues are removed, place

Source: http://pharmacopoeia.gov.uk/custom/files/MSDS/MSDS_6epidoxycycline%20hydrochloride_Cat871.pdf

Microsoft word - inci liste saluterra oktober 2012.doc

Aqua, Glycerol, Aloe Barbadensis, Potassium Sorbate Aqua, Glycerol, Hamamelis Virginiana, Potassium Sorbate Aqua, Glycerol, Aesculus Hippocastanum, Potassium Sorbate Aqua, Glycerol, Hibiskus Sabdariffa , Sorbic Acid Aqua, Glycerol, Betonica officinalis, Potassium Sorbate Aqua, Glycerol, Panax Ginseng , Potassium Sorbate 50% Hydrolyzed Silk, Aqua, Glycerol, Potassium Sorbate 50% Solubl

Procedimentos 2011 sem capa.pdf

Analgésicos Remifentanil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 334 Anestésicos Ketamina . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

© 2010-2018 Modern Medicine